Robeco Institutional Asset Management B.V. reduced its holdings in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 6.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,879 shares of the electronics maker's stock after selling 13,166 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.19% of Dolby Laboratories worth $13,581,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of DLB. Alpine Bank Wealth Management purchased a new stake in shares of Dolby Laboratories during the first quarter worth $25,000. Cheviot Value Management LLC bought a new position in Dolby Laboratories in the 1st quarter worth about $27,000. MAI Capital Management boosted its stake in Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after purchasing an additional 162 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories during the 1st quarter valued at about $29,000. Finally, Global X Japan Co. Ltd. bought a new stake in shares of Dolby Laboratories during the first quarter valued at about $51,000. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Dolby Laboratories Stock Down 0.3%
DLB opened at $71.27 on Friday. The business's fifty day simple moving average is $72.64 and its 200 day simple moving average is $74.46. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66. The stock has a market cap of $6.83 billion, a PE ratio of 26.10 and a beta of 0.92.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. The firm had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, equities analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's payout ratio is presently 48.35%.
Insiders Place Their Bets
In related news, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $71.66, for a total value of $1,791,500.00. Following the transaction, the chief executive officer owned 114,725 shares in the company, valued at $8,221,193.50. This trade represents a 17.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Shriram Revankar sold 7,000 shares of the business's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company's stock, valued at $5,276,990.20. This represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 99,366 shares of company stock valued at $7,293,963 in the last ninety days. 38.39% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
DLB has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Rosenblatt Securities reissued a "buy" rating and issued a $95.00 price target on shares of Dolby Laboratories in a report on Friday, August 1st. Tigress Financial upped their price target on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a report on Friday, August 15th. Weiss Ratings reissued a "hold (c)" rating on shares of Dolby Laboratories in a research note on Saturday, September 27th. Finally, Robert W. Baird started coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 target price for the company. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $95.75.
Get Our Latest Stock Report on Dolby Laboratories
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.